Blog – Page 23 – PRAIS 2.0

Home
Blog

BD Provides Update on Voluntary Recall of Certain BD Alaris™ Pump Infusion Sets

Murilo Freitas - 04:00, 14 de September de 2025219

FRANKLIN LAKES, N.J. (Sept. 12, 2025) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today expanded their Class I voluntary recall initiated in the United States on July 8, 2025 and expanded on July 17, 2025 to inform customers of worst-case performanc

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/bd-provides-update-voluntary-recall-certain-bd-alaristm-pump-infusion-sets

FDA Launches Real-Time Adverse Event Reporting Dashboard for Cosmetic Products

Murilo Freitas - 20:08, 11 de September de 2025168

FDA Launches Real-Time Adverse Event Reporting Dashboard for Cosmetic Products
http://www.fda.gov/news-events/press-announcements/fda-launches-real-time-adverse-event-reporting-dashboard-cosmetic-products

Update on Alert: Defibrillation Lead Issue from Boston Scientific

Murilo Freitas - 04:00, 11 de September de 2025200

This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program.

http://www.fda.gov/medical-devices/medical-device-recalls/update-alert-defibrillation-lead-issue-boston-scientific

Ventilator Recall: Philips Respironics Removes Certain DreamStation Devices Due to Programming Errors That Can Result in Failed Therapy Modes

Murilo Freitas - 04:00, 11 de September de 2025186

DreamStation devices may deliver incorrect therapy due to programming errors. Continued use could cause ineffective treatment or harm.

http://www.fda.gov/medical-devices/medical-device-recalls/ventilator-recall-philips-respironics-removes-certain-dreamstation-devices-due-programming-errors

Accolade Pacemaker Devices by Boston Scientific and Potential Need for Early Device Replacement – FDA Safety Communication

Murilo Freitas - 04:00, 10 de September de 2025422

Read the FDA’s recommendations related to Accolade pacemaker devices by Boston Scientific and a potential need for early device replacement.

http://www.fda.gov/medical-devices/safety-communications/accolade-pacemaker-devices-boston-scientific-and-potential-need-early-device-replacement-fda-safety

HHS, CBP Seize $86.5 Million Worth of Illegal E-Cigarettes in Largest-Ever Operation

Murilo Freitas - 19:01, 9 de September de 2025307

HHS, CBP Seize $86.5 Million Worth of Illegal E-Cigarettes in Largest-Ever Operation
http://www.fda.gov/news-events/press-announcements/hhs-cbp-seize-865-million-worth-illegal-e-cigarettes-largest-ever-operation

FDA Issues New Guidance to Expand Non-Opioid Options for Chronic Pain, Curb Misuse

Murilo Freitas - 13:04, 9 de September de 2025354

FDA Issues New Guidance to Expand Non-Opioid Options for Chronic Pain, Curb Misuse
http://www.fda.gov/news-events/press-announcements/fda-issues-new-guidance-expand-non-opioid-options-chronic-pain-curb-misuse

PAHO launches initiative to curb rising suicide rates in the Americas

admin - 12:00, 9 de September de 2025338

PAHO launches initiative to curb rising suicide rates in the Americas

Cristina Mitchell

10 Sep 2025

FDA Launches Crackdown on Deceptive Drug Advertising

Murilo Freitas - 22:41, 8 de September de 2025259

FDA Launches Crackdown on Deceptive Drug Advertising
http://www.fda.gov/news-events/press-announcements/fda-launches-crackdown-deceptive-drug-advertising

WHO updates list of essential medicines to include key cancer, diabetes treatments

admin - 15:36, 7 de September de 2025434

WHO updates list of essential medicines to include key cancer, diabetes treatments

Cristina Mitchell

8 Sep 2025

PRAIS 2.0